Bernie Sanders places hold on FDA commissioner nominee, citing ties to Big Pharma

Surging Democratic presidential candidate Sen. Bernie Sanders of Vermont said he will try to block the nomination of President Obama's nominee to be the next FDA commissioner, Dr. Robert Califf, currently the deputy commissioner for medical products and tobacco. "Dr. Califf's extensive ties to the pharmaceutical industry give me no reason to believe that he would make the FDA work for ordinary Americans, rather than just the CEOs of pharmaceutical companies," Sanders said. Sen. Edward Markey (D-MA) also said he is placing a hold on Califf's nomination because he wants the FDA to overhaul its process for approving opioid painkillers, whose addictive nature is leading to an epidemic of overdose deaths and sparking a national conversation about drug abuse. Califf is still expected to win the Senate's approval. Although Califf's ties to Big Pharma are the chief concern of some Democrats on Capitol Hill, the cardiologist has also had a hand in the creation of pro device industry sections of the 21st Century Act that are being promoted by AdvaMed. More

Suggested Articles

At the two-year mark, the data show TAVR and open surgery patients are equivalent when it comes to risks of stroke, hospitalization and death.

Abbott launched a rapid coronavirus test able to deliver positive results in as little as five minutes from a tabletop box the size of a toaster.

The FDA will be working with government and public-private partners to distribute and evaluate 3D designs and models.